Helpline Tollfree +1.800.650.8239 info@clearsynth.com

OUR QUALITY: ISO 9001:2015 | ISO 14001:2015 | OHSAS 18001:2007 | ISO Guide 34:2009 | ISO/IEC 17025:2005

We speak your language 

Darifenacin Open chain

Impurities
CAT No.
:
CS-O-16014

CAS No.

:

NA

Molecular Weight

:

507.46

Molecular Formula

:

C28H31BrN2O2

Purity

:

>98 %

Inventory Status:

:

Available for Immediate Shipment

HS Code:

:

29049090

 


Useful information

"Darifenacin (trade name Enablex in US and Canada, Emselex in Europe) is a medication used to treat urinary incontinence. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis. In 2010 the US rights were sold to Warner Chilcott for 400 million US$.",""



Product Application Notes

Impurity in commercial preparations of Darifenacin.



Synonyms

(S)-2-(1-(3-(2-bromoethyl)-4-hydroxyphenethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide



MSDS



Have any questions ?

We normally respond within 8 hours.

Subject :

  Stock Status

  Bulk Pricing

  Custom QTY Quote

  Request MSDS

  Request COA

  Other






Page info:

This page contains information about Darifenacin Open chain Cas # NA and its Impurities.

Darifenacin Open chain Darifenacin Open chain Worldwide Suppliers of Darifenacin Open chain Impurities Clearsynth NA

Product rating: 9 Darifenacin Open chain based on 20 ratings

  1. Impurities

  2. Darifenacin Open chain



Keywords

Keywords: Darifenacin Open chain, CS-O-16014, NA, (S)-2-(1-(3-(2-bromoethyl)-4-hydroxyphenethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide, C28H31BrN2O2, 507.46, Impurity in commercial preparations of Darifenacin.
Internal standard, Internal standard Darifenacin, HPLC-MS method validation, HPLC-MS method validation Darifenacin, LC-MS-MS method validation, LC-MS-MS method validation Darifenacin, Deuterated internal standard, Deuterated internal standard Darifenacin, Deuterated Darifenacin, Deuterium labeled Darifenacin, Quantitative bioanalytical methods, Quantitative bioanalytical methods Darifenacin, Blood samples Darifenacin, Blood concentrations, Heavy drugs, Analysis, Analysis Darifenacin, Clinical diagnostic, Clinical diagnostic Darifenacin, Dosing Darifenacin, Analytical method development, Internal standard method.



Related result for 'Darifenacin Open chain'

- Darifenacin : API Standards

- Darifenacin : Stable Isotopes

- Darifenacin : Metabolites

- Darifenacin : Impurities

- Darifenacin : Intermediates



QUICK ENQUIRY

Specific product requirements



Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form :(






NORTH AMERICAN SALES AND R&D CENTRE

CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060

ASIA R&D CENTRE

CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
Hyderabad- 500076,
Telangana, India.
T : +91-40-27155481

ASIA OFFICE

CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
India
T : +91-22-45045945